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The intracellular penetration and activity of linezolid in human polymorphonuclear leukocytes and tissue-
cultured cells (McCoy) were evaluated. Linezolid reached intracellular concentrations slightly greater than
extracellular ones in both types of cell. The uptake was rapid and not saturable and was affected by environ-
mental temperature and cell viability. Linezolid showed slight intracellular activity against Staphylococcus
epidermidis at high extracellular concentrations.
The penetration and intracellular activity of antimicrobial
agents in phagocytes are particularly important under condi-
tions in which the infecting microorganism is able to survive
and multiply. Several infecting bacteria, however, are able to
multiply within nonphagocytic cells, particularly epithelial
cells. For these infections, the use of agents capable of accu-
mulating and remaining active in such cells could be of poten-
tial clinical interest (9). The high intracellular accumulation of
an antimicrobial agent does not always mean good intracellular
activity. It is important, then, to evaluate whether intracellular
antimicrobial agents remain active against bacteria. Linezolid
is an oral oxazolidinone antibacterial agent that acts by inhib-
iting bacterial protein synthesis (4, 13–15) and has a wide
spectrum of activity against gram-positive organisms includ-
ing methicillin-resistant Staphylococcus aureus, penicillin- and
cephalosporin-resistant pneumococci, and vancomycin-resis-
tant Enterococcus faecalis and Enterococcus faecium, as well as
anaerobes such as Clostridium spp., Peptostreptococcus spp.,
and Prevotella spp. (1, 5–7). Linezolid is bacteriostatic against
most susceptible organisms, but displays bactericidal activity
against some strains of pneumococci, Bacteroides fragilis, and
Clostridium perfringens. (2, 3). There is no information about
the intracellular pharmacology of these compounds in human
phagocytes and nonphagocytic cells. The purpose of this study
is to evaluate the uptake of linezolid by phagocytes (polymor-
phonuclear leukocytes [PMNs]) and nonphagocytic cells (Mc-
Coy). The intracellular activities of this compound against
Staphylococcus aureus and Staphylococcus epidermidis were
also evaluated.
The uptake of radiolabeled linezolid (167 Ci/mg; Pharma-
cia.) by phagocytes and nonphagocytic cells was determined by
a velocity gradient centrifugation technique, as described by
Klempner and Styrt (8). In these experiments, phagocytes or
tissue-cultured cells were incubated in Hanks’ balanced salt
solution containing different concentrations of linezolid (1 to
40 g/ml). After different periods of incubation at 37°C, the
cells were separated from the extracellular solution by centrif-
ugation through a water-impermeable silicone oil barrier in a
microcentrifuge tube. A 10-l aliquot of the extracellular me-
dium and the entire cell pellet, obtained by cutting off the
portion of the microcentrifuge tube containing the pellet, were
placed in 3 ml of scintillation fluid (Ready Micro; Beckman
Instruments, Inc., Fullerton, Calif.) and counted with a liquid
scintillation counter (model LS 1801; Beckman). The intracel-
lular water space was measured by using tritiated water and the
extracellular marker [14C]polyethylene glycol (1.4 mCi/g; Am-
ersham International, Plc., Buckinghamshire, United King-
dom). The cells were incubated with these radiolabeled com-
pounds for 2 min at 37°C, and then the cells were separated
from extracellular fluid by velocity gradient centrifugation and
counted with a liquid scintillation counter. The total water
content of the cell pellet was corrected for trapped extracellu-
lar water (i.e., polyethylene glycol space) to obtain the intra-
cellular water space. The accumulation rate of the antimicro-
bial agent in PMN (cell-associated drug) or tissue-cultured
cells was calculated and expressed as a cellular/extracellular
concentration (C/E) ratio (11). The data are expressed as
means  standard deviations. Differences between groups
were compared by variance analysis, used to assess statistical
significance at P  0.05.
Figure 1 shows the kinetics of the uptake of linezolid by
human PMNs and McCoy cells. The intracellular penetration
of linezolid was rapid, reaching intracellular concentrations 1.2
times higher than the extracellular concentrations after 20 min
of incubation in both kinds of cells. After 180 min of incuba-
tion, the C/E ratio values remained the same for McCoy cells,
but had decreased by around 50% in PMNs. To evaluate
whether linezolid that had been taken up by human PMNs was
tightly bound to cellular components, we evaluated the kinetics
of efflux (Fig. 2). The elution of linezolid from human PMN
was rapid. After 10 min of incubation in an antimicrobial-free
medium, 90% of linezolid was released. The intracellular pen-
etration of linezolid into PMN and McCoy cells was not satu-
rable at extracellular concentrations ranging from 1 to 40 mg/
liter. The C/E ratios in PMNs ranged from 0.9 (extracellular
concentration, 40 mg/liter) to 1.3 (extracellular concentration,
20 mg/liter). At the same extracellular concentration, the C/E
ratios ranged from 1.1 (extracellular concentration, 40 mg/
liter) to 1.3 (extracellular concentrations, 1, 5, and 20 mg/liter)
in McCoy cells.
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Further studies to elucidate the mechanisms for linezolid
uptake by PMNs were performed as described previously (10).
The influence of environmental temperature (4 versus 37°C),
cell viability, and pH (5 to 8) and the effects of human serum,
pooled serum (5 and 10%), and metabolic inhibitors (1.5 
103 M [each] sodium fluoride and sodium cyanide; Sigma
Chemical Co., St. Louis, Mo.) on the uptake of linezolid by
PMNs were evaluated. The intracellular penetration of lin-
ezolid in PMNs was also measured after stimulating the cells
with 200 nM phorbol myristate acetate (PMA; Sigma) and
after phagocytosis of opsonized staphylococci (in 5% pooled
human serum at a 10/1 ratio of bacteria to PMNs) and opso-
nized zymosan (0.9 mg/liter; Sigma) (Table 1). Cell-associated
linezolid decreased in viable cells at 4°C (C/E ratio, 0.75 
0.15; control, 1.2  0.4) and increased significantly (P  0.05)
when dead cells at 37°C were used (C/E ratio, 1.98  0.15). A
possible explanation for this increase might be that the forma-
lin used to kill PMNs caused structural changes in the PMNs,
which favored nonspecific binding of the linezolid. This hy-
pothesis is currently under investigation. The uptake of this
new oxazolidinone was not affected by external pH (which
ranged from 5 to 8). Concentrations of pooled human serum
and different metabolic inhibitors (NaCN and NaF) did not
affect the intracellular penetration of this antimicrobial agent.
Neither stimulation of the PMNs by a membrane activator
(PMA) nor phagocytosis of opsonized S. aureus and zymosan
significantly affected the intracellular penetration of linezolid.
Most data indicated that a possible passive mechanism was
involved in the intracellular penetration of this agent (7, 12).
To evaluate the intracellular activities of antimicrobial
agents, a previously described method was used (11). S. aureus
ATCC 25923 and S. epidermidis ATCC 41134 were used for
killing assays. Susceptibility studies were determined by mi-
crodilution assay. The MICs of linezolid for these strains were
2 and 1 mg/liter, respectively. The data were expressed as
percentages of surviving staphylococci compared with the con-
trol levels (without antimicrobial agents) at 3 h. In addition to
determining bacterial survival, morphological studies were also
routinely performed, at time zero and after 3 h of incubation,
to evaluate the disposition of bacteria (cell associated or ex-
tracellular). All assays were performed in duplicate with PMNs
from five different donors. The data are expressed as means 
FIG. 1. Kinetics of linezolid uptake by human PMNs and McCoy cells (n  4). Experiments were carried out at extracellular concentrations
of 10 mg/liter at 37°C. Data are expressed as means  standard deviations.
FIG. 2. Efflux of linezolid from human PMNs (n  3). After incu-
bation with 10 mg of linezolid per liter for 20 min, the cells were
washed and resuspended in antimicrobial agent-free medium. Cell-
associated linezolid was then measured at different times.
TABLE 1. Effects of various conditions on intracellular
penetration of linezolid in human PMNsa
Condition C/E ratiob
Control (viable cells, 37°C, pH 72) ......................................1.20  0.40
Viable cells, 4°C......................................................................0.75  0.17c
Dead cells, 37°C......................................................................1.98  0.15c
pH
5 ............................................................................................1.30  0.42
6 ............................................................................................1.13  0.171
7 ............................................................................................1.18  0.39
8 ............................................................................................1.20  0.14
Sodium cyanide.......................................................................1.25  0.21




Opsonized PMA .....................................................................1.25  0.21
Opsonized S. aureus ...............................................................1.35  0.13
Zymosan................................................................................... 1.3  0.27
a The conditions examined include environmental temperature, cell viability,
external pH, metabolic inhibitors, serum, membrane activation, and phagocytosis
of S. aureus and zymosan.
b Experiments (n  4) were carried out for 20 min at extracellular concentra-
tions of 10 mg/liter.
c P  0.05 compared with the control.
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standard deviations. Differences between groups were com-
pared by variance analysis, which was used to assess statistical
significance at P  0.05. At extracellular concentrations attain-
able in human serum, linezolid did not affect the intracellular
survival of staphylococci. At high extracellular concentrations
(10 and 20 mg/liter), linezolid showed slight intracellular ac-
tivity against S. epidermidis, but not against S. aureus (Fig. 3).
The differences in the intracellular activity might be related to
differences in the intrinsic activity of this compound against
both strains.
In summary, linezolid penetrates both phagocytes and non-
phagocytic cells, reaching intracellular concentrations slightly
greater than the extracellular ones. Linezolid showed slight
intracellular activity against S. epidermidis at high intracellular
concentrations.
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FIG. 3. Activity of linezolid against intracellular S. aureus and S.
epidermidis in human PMNs (n  4). Data are expressed as percent-
ages of surviving bacteria after 3 h of incubation compared to those of
the controls without linezolid (means  standard deviations). *, P 
0.05 compared with control.
VOL. 46, 2002 NOTES 4015
 on July 31, 2017 by U
S
E
/B
C
T
A
.G
E
N
 U
N
IV
E
R
S
IT
A
R
IA
http://aac.asm
.org/
D
ow
nloaded from
 
